Arye L. Hillman | Academic Influence

Arye L. Hillman's AcademicInfluence.com Rankings

Arye L. Hillman

Economics

#3306

World Rank

#3748

Historical Rank

economics Degrees

Download Badge

Economics

Arye L. Hillman's Degrees

PhD Economics University of Chicago
Masters Economics University of Chicago
Bachelors Economics University of Chicago

Similar Degrees You Can Earn

Why Is Arye L. Hillman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Arye L. Hillman is an Israeli economist whose career has been at Bar Ilan University in Israel where he has been William Gittes Chair and Professor of Economics. His main research focus is on political economy, or the study of public policy as the interface between economic and political decisions. From 1994 to 2014 he was an editor of the European Journal of Political Economy for which he remained editorial advisor and editor of various special issues.

(See a Problem?)

Arye L. Hillman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organizations? (1989) (480)
Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. (1991) (258)
Financial Incentives for Physicians in HMOs (1987) (241)
Economic Analysis of Health Care Technology: A Report on Principles (1995) (210)
Physician financial incentives and feedback: failure to increase cancer screening in Medicaid managed care. (1998) (183)
Issues in the Cross-National Assessment of Health Technology (1992) (172)
The Use of Physician Financial Incentives and Feedback to Improve Pediatric Preventive Care in Medicaid Managed Care (1999) (167)
A Reappraisal of Hepatitis B Virus Vaccination Strategies Using Cost-Effectiveness Analysis (1993) (165)
Contractual Arrangements Between HMOs and Primary Care Physicians: Three-Tiered HMOs and Risk Pools (1992) (124)
Hospital adoption of medical technology: an empirical test of alternative models. (1995) (109)
Financial incentives and drug spending in managed care. (1999) (100)
Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. (1992) (95)
Managing the physician: rules versus incentives. (1991) (93)
Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. (1989) (93)
Diffusion of Laparoscopic Cholecystectomy Among General Surgeons in the United States (1995) (84)
A Comparison of International Health Outcomes and Health Care Spending (1994) (82)
Toward new typologies for HMOs. (1990) (76)
Health maintenance organizations, financial incentives, and physicians' judgments. (1990) (75)
Financial incentives for physicians in HMOs. Is there a conflict of interest? (1987) (75)
Competing Practice Guidelines: Using Cost-Effectiveness Analysis To Make Optimal Decisions (1998) (68)
Impact of a Mandatory Medicaid Case Management Program on Prenatal Care and Birth Outcomes: A Retrospective Analysis (1991) (66)
Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia. (1995) (61)
SCOPE, TIMING AND STRATEGIC ADJUSTMENT IN EMERGING MARKETS: MANUFACTURER STRATEGIES AND THE CASE OF MRI (1993) (49)
Managing Physician Incentives in Managed Care: The Role of For-Profit Ownership (1990) (48)
HMO managers' views on financial incentives and quality. (1991) (46)
The Adoption and Diffusion of CT and MRI in the United States: A Comparative Analysis (1985) (44)
Competitive behavior in the HMO marketplace. (2002) (37)
The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia. (1996) (30)
The diffusion of MRI: patterns of siting and ownership in an era of changing incentives. (1986) (29)
Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease. (1994) (28)
Reasons for Increasing Administrative Costs in Hospitals (1993) (22)
Patient-Motivated Prevention of Lifestyle-Related Disease in Japan (2007) (19)
Does income influence demand for medical services despite Japan's “Health Care for All” policy? (2008) (19)
Primary care physician turnover in HMOs. (1994) (19)
How Important is the Scientific Literature in Guiding Clinical Decisions?: The Case of Magnetic Resonance Imaging (1993) (18)
EFFECTS OF AN INCREASE IN PATIENT COPAYMENTS ON MEDICAL SERVICE DEMANDS OF THE INSURED IN JAPAN (2003) (18)
Mediators of patient trust. (1998) (18)
Measuring the economic impact of perioperative total parenteral nutrition: principles and design. (1988) (16)
Hospitals' motivations in establishing or closing geriatric evaluation management units: diffusion of a new patient-care technology in a changing health care environment. (1993) (16)
Declining Cost-Effectiveness of Screening for Disease: The Case of Gastric Cancer in Japan (1995) (15)
An academic medical center's experience with mandatory managed care for Medicaid recipients (1991) (14)
Economic decision making in healthcare. A standard approach to discounting health outcomes. (1995) (10)
The Effects of Health Insurance on Access to New Medical Technologies (1997) (10)
The Effect of a Redistribution System for Health Care for the Elderly on the Financial Performance of Health Insurance Societies in Japan (1998) (9)
Abruptly changing patterns of diffusion and use of extracorporeal shock-wave renal lithotripsy. (1991) (9)
The future catches up: a medical school curriculum in health economics. (2000) (7)
Perspectives: Safeguarding Quality In Managed Competition (1993) (7)
Gene therapy: socioeconomic and ethical issues. A roundtable discussion. (1996) (7)
The impact of physician financial incentives on high-risk populations in managed care. (1995) (6)
After the Challenger (1986) (6)
Health Policy in Transition: Terminal Care and Site of Death in Japan (1998) (6)
Economic Decision Making in Healthcare (1995) (5)
Omeprazole or Ranitidine Plus Metoclopramide for Patients with Severe Erosive Oesophagitis (1995) (5)
Cost-Effectiveness Opportunities for New Antibiotics (2012) (5)
Applied pharmacoeconomics. When can publication be legitimately withheld? (1997) (5)
Safeguarding quality in managed competition. (1993) (5)
The Cost-effectiveness of Misoprostol (1991) (3)
Idarubicin More Cost-Effective than Daunorubicin? (2012) (3)
Cost-effectiveness: from whose perspective? (1995) (2)
Consensus on early intervention in community-acquired pneumonia: Panel discussion (1996) (2)
After the Challenger. Biomedical opportunities in space. (1986) (2)
Clinical and economic consensus on early intervention in community-acquired pneumonia (1996) (1)
FINANCIAL INCENTIVES. COMMENT. AUTHOR'S REPLY (1990) (1)
Cost Effectiveness of Hepatitis B Immunisation Strategies (1994) (1)
Competitive behavior in the HMO marketplace: HMOs do not appear to extract more profits from consumers in markets dominated by for-profit firms than in markets where their share is smaller. (2002) (1)
Early patterns of diffusion, organization and use of ESWL. (1989) (1)
Cost-containment incentives in HMOs. What's known, what's not known. (1989) (1)
HMO behavior and stock market valuation: what does Wall Street reward and punish? (2001) (1)
Exemplary quality improvement programs in HMOs. (1995) (1)
Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation? (2004) (1)
Cost and Effectiveness of Hepatitis B Immunization (1993) (0)
Book Review The Wellness Encyclopedia: The comprehensive family resource for safeguarding health and preventing illness By the Editors of the University of California, Berkeley, Wellness Letter. 541 pp., illustrated. Boston, Houghton Mifflin, 1991. $29.95. (1991) (0)
The Economic Effects of Reform on Innovation (1995) (0)
Financial incentives and drug spending in managed care. (1999) (0)
COMMENTARY (2004) (0)
Physician Financial Incentives in Managed Care: Their Impact on Healthcare for the Elderly (1995) (0)
Safeguarding Quality In Managed (2001) (0)
Physician-executives can be mediators. (1986) (0)
Disclosing information and treating patients as customers. A review of selected issues. (1991) (0)
Understanding the Impact of Health Policy : 10% Co-payments for Medical Services Reduce Compliance with Necessary Care Among Elderly Patients with Chronic Disease in Japan (2006) (0)
Book ReviewThe Physician as Manager (1987) (0)
Book Review Cost-Effectiveness in Health and Medicine Edited by Marthe R. Gold, Joanna E. Siegel, Louise B. Russell, and Milton C. Weinstein. 425 pp. New York, Oxford University Press, 1996. $47.50. 0-19-510824-8 (1997) (0)
It's time to tell patients the facts about managed care. (1995) (0)
Reputation and Disenrollment (1998) (0)
Commentary: burden of proof in an era of outcomes research and managed care. (1998) (0)
A reappraisal of hepatitis B virus vaccination strategies using cost‐effectiveness analysis (1993) (0)
Applied Pharmacoeconomics (1997) (0)
Reputation and Disenrollment : Role of Consumer Information in Health Insurance Markets (1998) (0)
Competition Perspectives : Safeguarding Quality In Managed (2001) (0)
Principles of Economic Analysis of Health Care Technology (1996) (0)
Mentors' Perceptions of the Ready for Life Program: An Inclusion Program at Hope College (2014) (0)

This paper list is powered by the following services:

Other Resources About Arye L. Hillman

en.wikipedia.org

What Schools Are Affiliated With Arye L. Hillman?

Arye L. Hillman is affiliated with the following schools: